Johnson & Johnson Raises Quarterly Dividend by 4.2%
Continuing a Tradition of Dividend Growth
Johnson & Johnson has announced a 4.2% increase in its quarterly dividend, marking the 62nd consecutive year of dividend growth for the renowned healthcare company.
Enhanced Payout
The quarterly dividend has been raised from $1.19 to $1.24 per share, reflecting an annualized rate of $4.96 per share compared to the previous rate of $4.76.
Key Dates for Shareholders
Shareholders on record by the close of business on May 21, 2024, will qualify for the next dividend payment scheduled for June 4, 2024. The ex-dividend date, signaling when the stock trades without the upcoming dividend, is set for May 20, 2024.
Leadership in Healthcare Innovation
Johnson & Johnson is recognized as a leader in the healthcare industry, known for its pioneering advancements in medicine and medical technology. The company is committed to tackling complex health challenges through the development of smarter and less invasive treatments, emphasizing personalized healthcare solutions.
Source
The information provided in this report is sourced from a press release statement issued by Johnson & Johnson, highlighting the company's commitment to delivering value to its shareholders through consistent dividend growth.
